{"public_id":"cl_7422b10422133847ca1760aa3eba6175","status":"active","superseded_by_public_id":null,"corpus_id":6353210,"text":"Immunocompromised patients are the main group affected by invasive and disseminated fusariosis, whereas superficial and localized disease occurs mostly in immunocompetent patients.","confidence":0.96,"paper":{"corpus_id":6353210,"title":"Fusarium Infections in Immunocompromised Patients","url":"https://sah.borca.ai/papers/6353210"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_317660c62cb95dfe7d9ab5512a0f0fb3","name":"fusariosis","description":"An infection caused by Fusarium species that can range from superficial disease to disseminated infection.","types":["infection"],"url":"https://sah.borca.ai/concepts/co_317660c62cb95dfe7d9ab5512a0f0fb3"},{"public_id":"co_33c20a5e73394a6195f8aedf1066e5b1","name":"immune status of the host","description":"The level and functional state of a person's immune system that influences disease expression.","types":["host factor"],"url":"https://sah.borca.ai/concepts/co_33c20a5e73394a6195f8aedf1066e5b1"},{"public_id":"co_a27bfc28ce5fc787f5b388d33315bfcf","name":"immunocompromised patients","description":"Patients with impaired immune function who are at increased risk for invasive fungal infection.","types":["patient group"],"url":"https://sah.borca.ai/concepts/co_a27bfc28ce5fc787f5b388d33315bfcf"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7422b10422133847ca1760aa3eba6175"}